VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F10. A total of 2 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $480,000 | -76.1% | 5,500 | -78.3% | 0.00% | -77.8% |
| Q1 2016 | $2,011,000 | -96.0% | 25,300 | -93.9% | 0.01% | -93.0% |
| Q3 2015 | $50,098,000 | +11.0% | 413,207 | +13.1% | 0.13% | -49.4% |
| Q2 2015 | $45,122,000 | +111.9% | 365,423 | +102.5% | 0.26% | +94.7% |
| Q1 2015 | $21,289,000 | +5913.8% | 180,465 | +5951.8% | 0.13% | +6450.0% |
| Q4 2014 | $354,000 | -97.9% | 2,982 | -98.7% | 0.00% | -98.0% |
| Q1 2014 | $16,547,000 | -16.7% | 233,978 | -10.7% | 0.10% | -20.6% |
| Q3 2013 | $19,869,000 | -5.5% | 262,051 | -0.4% | 0.13% | -19.7% |
| Q2 2013 | $21,028,000 | – | 263,030 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|